skip to the main content area of this page

March 2017 – United States: Drug Enforcement Administration to issue a temporary order on para-Fluoroisobutyrfentanyl after fatal intoxications

WASHINGTON, D.C., United States – March 2017: On 23 March, 2017, the United States Drug Enforcement Administration (DEA) notified of the intent to issue a temporary order to schedule the synthetic opioid para-fluoroisobutyrfentanyl (also known as para-fluoroisobutyrylfentanyl) into Schedule I pursuant to the provisions of the Controlled Substances Act (CSA). Substances in Schedule I of the CSA are those that have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. In the United States at least 62 overdose deaths involving the use of para-fluoroisobutyrfentanyl have been confirmed in Maryland in 2016. A recent UNODC publication called “Fentanyl and its analogues - 50 years on” provides further information on the global emergence of fentanyl analogues and their health risks.

For more information, please see:

Federal Register of the United states Government “Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl Into Schedule I” –

UNODC Report on “Fentanyl and its analogues - 50 years on” –

UNODC EWA news clip on “Fentanyl and its analogues explored in the Global SMART Update 17” –

go back